184 related articles for article (PubMed ID: 35767889)
1. Anti-Ro52 Antibody as a Protective Factor for Pulmonary Fibrosis in Primary Sjögren's Syndrome.
Li D; Li H; Li W; Zhu T
Iran J Immunol; 2022 Jun; 19(2):161-171. PubMed ID: 35767889
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
3. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
[TBL] [Abstract][Full Text] [Related]
4. The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.
Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; Deprez J; Van den Bosch F; Elewaut D; Peene I
Clin Exp Rheumatol; 2022 Dec; 40(12):2310-1317. PubMed ID: 36200940
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
7. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome.
Wei P; Li C; Qiang L; He J; Li Z; Hua H
Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e156-60. PubMed ID: 25475778
[TBL] [Abstract][Full Text] [Related]
8. Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Kvarnström M; Brokstad KA; Jonsson R; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2014 Jul; 177(1):244-52. PubMed ID: 24673429
[TBL] [Abstract][Full Text] [Related]
9. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
[TBL] [Abstract][Full Text] [Related]
10. Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren's syndrome and Sicca.
Chiang S; Grogan T; Kamounah S; Wei F; Tayob N; Kim JY; Kyun Park J; Akin D; Elashoff DA; Pedersen AML; Song YW; Wong DTW; Chia D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599651
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome.
Song JS; Do JH; Lee SW
Rheumatol Int; 2012 Feb; 32(2):491-5. PubMed ID: 21246358
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
13. Circulating Th2 cell reduction and Th1/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease.
Shi L; Wang J; Guo HX; Han XL; Tang YP; Liu GY
Arthritis Res Ther; 2022 May; 24(1):121. PubMed ID: 35606782
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
Gál I; Lakos G; Zeher M
Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory features of childhood-onset primary Sjögren's syndrome: A retrospective study from China.
Liu C; Jin Y; Huang H; Ding F; Xu X; Bao S; Yang Z; Jin Y
Front Pediatr; 2022; 10():1044812. PubMed ID: 36683822
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
Liu K; Liao Y; Li P; Shi J
J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody].
Han YJ; Li CH; Chen XY; Zhao JX
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1000-1006. PubMed ID: 38101780
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
Dong X; Gao YL; Lu Y; Zheng Y
Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and immunological features of primary Sjögren's syndrome patients with positive anti-centromere protein B antibody].
Meng YH; Chen YF; Zhou PR
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1088-1096. PubMed ID: 38101794
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
